Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9152 |
High Similarity |
NPD8312 |
Approved |
0.9152 |
High Similarity |
NPD8313 |
Approved |
0.8779 |
High Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8758 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.858 |
High Similarity |
NPD6559 |
Discontinued |
0.8553 |
High Similarity |
NPD3226 |
Approved |
0.8452 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8436 |
Intermediate Similarity |
NPD6778 |
Approved |
0.8436 |
Intermediate Similarity |
NPD6777 |
Approved |
0.8436 |
Intermediate Similarity |
NPD6781 |
Approved |
0.8436 |
Intermediate Similarity |
NPD6782 |
Approved |
0.8436 |
Intermediate Similarity |
NPD6776 |
Approved |
0.8436 |
Intermediate Similarity |
NPD6779 |
Approved |
0.8436 |
Intermediate Similarity |
NPD6780 |
Approved |
0.8402 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8385 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8353 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8297 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.8294 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8263 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8246 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8239 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.8208 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8205 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.8198 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8197 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.8197 |
Intermediate Similarity |
NPD7697 |
Approved |
0.8197 |
Intermediate Similarity |
NPD7698 |
Approved |
0.8156 |
Intermediate Similarity |
NPD6535 |
Approved |
0.8156 |
Intermediate Similarity |
NPD6534 |
Approved |
0.8152 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.8152 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.815 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8142 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.8129 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.8121 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8121 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8118 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.8107 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8103 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8101 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.8101 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.8101 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.8098 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.8084 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8081 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8072 |
Intermediate Similarity |
NPD5402 |
Approved |
0.807 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8032 |
Intermediate Similarity |
NPD7874 |
Approved |
0.8032 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.8024 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8022 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.8022 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.8012 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8012 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8012 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8012 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7989 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7979 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7964 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7952 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7921 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7904 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7895 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7895 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7895 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7892 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7866 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7861 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7861 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7844 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7826 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7812 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7778 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7771 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.775 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.775 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7744 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7744 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7744 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7744 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7714 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7712 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7701 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7692 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7684 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7667 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7661 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7654 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7654 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7636 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7636 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7636 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7633 |
Intermediate Similarity |
NPD37 |
Approved |
0.7626 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7616 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7607 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7607 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7602 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7602 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7602 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7602 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7602 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7588 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7578 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7578 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7576 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7544 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7542 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7539 |
Intermediate Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.7527 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7516 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7516 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7485 |
Intermediate Similarity |
NPD1512 |
Approved |
0.747 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7469 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7469 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7469 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7469 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7469 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7451 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7451 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7438 |
Intermediate Similarity |
NPD8059 |
Phase 3 |
0.7438 |
Intermediate Similarity |
NPD8058 |
Clinical (unspecified phase) |
0.7436 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7429 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7425 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7416 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7409 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7407 |
Intermediate Similarity |
NPD8285 |
Discontinued |
0.7391 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7381 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7365 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7348 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7338 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7333 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7326 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7317 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7317 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7301 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7294 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7289 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7289 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7262 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7261 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7256 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7256 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7247 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7235 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7233 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7222 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7212 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7198 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7195 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7191 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7191 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7188 |
Intermediate Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.716 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.715 |
Intermediate Similarity |
NPD7930 |
Approved |
0.7143 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7143 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7126 |
Intermediate Similarity |
NPD2800 |
Approved |
0.712 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7117 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7108 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7098 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7091 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7086 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7086 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7056 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7055 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7052 |
Intermediate Similarity |
NPD2649 |
Approved |
0.7052 |
Intermediate Similarity |
NPD2651 |
Approved |
0.7048 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7037 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7037 |
Intermediate Similarity |
NPD411 |
Approved |
0.7037 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7035 |
Intermediate Similarity |
NPD920 |
Approved |
0.7033 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7033 |
Intermediate Similarity |
NPD7799 |
Discontinued |
0.702 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7018 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7018 |
Intermediate Similarity |
NPD4662 |
Approved |
0.7018 |
Intermediate Similarity |
NPD4661 |
Approved |
0.7006 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7006 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7005
|
Intermediate Similarity |
NPD7999 |
Approved |